v3.26.1
SEGMENTS INFORMATION - Segment Revenue, Significant Segment Expenses and Segment Operating EBITDA (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Equity in earnings (loss) of nonconsolidated affiliates $ 9 $ 9 $ 8 $ (6)
Healthcare & Water Technologies        
Segment Reporting [Line Items]        
Segment net sales 856 817 1,662 1,580
Cost of sales 524 505 1,020 983
Selling, general and administrative expenses 102 87 195 172
Research and development expenses 19 22 41 42
Amortization of intangibles & other segment items 43 48 86 97
Equity in earnings (loss) of nonconsolidated affiliates 1 0 2 0
Depreciation and amortization 89 93 180 185
Segment operating EBITDA 258 248 502 471
Diversified Industrials        
Segment Reporting [Line Items]        
Segment net sales 963 932 1,838 1,781
Cost of sales 642 626 1,213 1,194
Selling, general and administrative expenses 126 118 242 224
Research and development expenses 23 25 51 48
Amortization of intangibles & other segment items 24 26 48 52
Equity in earnings (loss) of nonconsolidated affiliates 0 0 (1) 0
Depreciation and amortization 65 62 130 121
Segment operating EBITDA $ 213 $ 199 $ 413 $ 384